Cargando…
A Neuroprotective Action of Quercetin and Apigenin through Inhibiting Aggregation of Aβ and Activation of TRKB Signaling in a Cellular Experiment
Alzheimer’s disease (AD) is a neurodegenerative disease with progressive memory loss and the cognitive decline. AD is mainly caused by abnormal accumulation of misfolded amyloid β (Aβ), which leads to neurodegeneration via a number of possible mechanisms such as down-regulation of brain-derived neur...
Autores principales: | Chiu, Ya-Jen, Teng, Yu-Shan, Chen, Chiung-Mei, Sun, Ying-Chieh, Hsieh-Li, Hsiu Mei, Chang, Kuo-Hsuan, Lee-Chen, Guey-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129860/ https://www.ncbi.nlm.nih.gov/pubmed/36646447 http://dx.doi.org/10.4062/biomolther.2022.136 |
Ejemplares similares
-
Flavones 7,8-DHF, Quercetin, and Apigenin Against Tau Toxicity via Activation of TRKB Signaling in ΔK280 Tau(RD)-DsRed SH-SY5Y Cells
por: Chiang, Ni-Ni, et al.
Publicado: (2021) -
Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein
por: Lin, Te-Hsien, et al.
Publicado: (2022) -
Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity
por: Chiu, Ya-Jen, et al.
Publicado: (2022) -
Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer’s disease cell and mouse models for neuroprotection and cognitive improvement
por: Chiu, Ya-Jen, et al.
Publicado: (2021) -
Using ΔK280 Tau(RD) Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy
por: Weng, Zheng-Kui, et al.
Publicado: (2023)